Jun Zhou

机构：Hubei University of Medicine, Peking University, People’s Hospital of Wenshan Prefecture, Peking University Cancer Hospital, China Agricultural University · ORCID：0000-0003-0570-1730

发表论文 92 篇 · 总被引 2690 次 · h-index 23

代表论文

• Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trial (2022 · BMC Medicine · 被引 84)
• Disitamab vedotin (RC48) plus toripalimab for HER2-expressing advanced gastric or gastroesophageal junction and other solid tumours: a multicentre, open label, dose escalation and expansion phase 1 trial (2024 · EClinicalMedicine · 被引 77)
• CT041 CAR T cell therapy for Claudin18.2-positive metastatic pancreatic cancer (2023 · Journal of Hematology & Oncology · 被引 71)
• Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase Trials (2024 · Journal of Clinical Oncology · 被引 50)
• Multi-omics of the gut microbial ecosystem in patients with microsatellite-instability-high gastrointestinal cancer resistant to immunotherapy (2024 · Cell Reports Medicine · 被引 31)
• Bibliometric Analysis of Acupuncture Therapy for Cancer Pain Over the Past 10 Years (2023 · Journal of Pain Research · 被引 22)